Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
572 stocks in Europe match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| NIOX.L | NIOX Group Plc | Healthcare | $392.35M | 66.60 GBP | −14.18% | +8.82% |
| EGTX.ST | Egetis Therapeutics AB (publ) | Healthcare | $390.51M | 7.87 SEK | 0.00% | +25.72% |
| CRNA.OL | Circio Holding ASA | Healthcare | $384.19M | 11.92 NOK | −17.57% | +37.80% |
| VOX.WA | Voxel S.A. | Healthcare | $376.42M | 134.20 PLN | −23.75% | +6.85% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| N3B.F | Anbio Biotechnology | Healthcare | $361.87M | 6.40 EUR | −84.62% | −24.26% |
| ALCLS.PA | Cellectis S.A. | Healthcare | $355.75M | 2.94 EUR | −39.30% | +16.59% |
| OPT.L | Optima Health plc | Healthcare | $355.51M | 240.50 GBP | −6.05% | +1.48% |
| HUM.ST | Humana AB (publ) | Healthcare | $350.23M | 71.70 SEK | −1.65% | +14.72% |
| ILM1.DE | Medios AG | Healthcare | $324.14M | 10.92 EUR | −37.39% | −1.62% |
| SBS.DE | Stratec SE | Healthcare | $322.43M | 22.85 EUR | −30.97% | +11.46% |
| NP5.DE | Newron Pharmaceuticals S.p.A. | Healthcare | $316.56M | 13.50 EUR | −61.04% | +8.87% |
| VICO.ST | Vicore Pharma Holding AB (publ) | Healthcare | $315.07M | 10.74 SEK | −41.12% | −0.74% |
| ANCR.L | Animalcare Group PLC | Healthcare | $314.33M | 335.00 GBP | −1.47% | 0.00% |
| MED.DE | MEDICLIN Aktiengesellschaft | Healthcare | $301.82M | 5.45 EUR | −2.68% | +31.64% |
| IDHC.L | Integrated Diagnostics Holdings plc | Healthcare | $298.80M | $0.55 | −34.61% | −9.00% |
| PIHLIS.HE | Pihlajalinna Oyj | Healthcare | $283.18M | 10.92 EUR | −36.88% | +5.61% |
| SUS.ST | Surgical Science Sweden AB (publ) | Healthcare | $279.10M | 50.85 SEK | −53.48% | +49.82% |
| TSTL.L | Tristel plc | Healthcare | $276.02M | 425.00 GBP | −5.56% | +1.19% |
| TRMED.OL | Thor Medical ASA | Healthcare | $268.94M | 6.76 NOK | −2.87% | +51.91% |
| TNG.PA | Transgene SA | Healthcare | $263.11M | 0.81 EUR | −46.27% | +12.57% |
| XUP.DE | Genfit S.A. | Healthcare | $258.22M | 14.08 EUR | −1.81% | −1.81% |
| ALMDT.PA | Median Technologies SA | Healthcare | $256.00M | 4.57 EUR | −37.14% | +15.84% |
| IDD.DE | Innate Pharma S.A. | Healthcare | $243.27M | 1.78 EUR | −15.24% | +12.80% |
| IPH.PA | Innate Pharma S.A. | Healthcare | $240.15M | 1.88 EUR | −19.40% | +19.01% |
| CLN.WA | Celon Pharma S.A. | Healthcare | $235.59M | 22.20 PLN | −5.53% | +5.21% |
| ALERS.PA | Eurobio Scientific Société anonyme | Healthcare | $232.43M | 19.80 EUR | −22.96% | −6.60% |
| STIL.ST | Stille AB | Healthcare | $216.03M | 225.00 SEK | −20.49% | −5.06% |
| AOTI.L | AOTI, Inc. | Healthcare | $205.47M | 142.50 GBP | −1.72% | +35.71% |
| ICE.WA | Medinice S.A. | Healthcare | $204.25M | 72.30 PLN | −23.97% | −6.35% |
| NORDH.OL | Nordhealth AS | Healthcare | $204.13M | 24.40 NOK | −37.11% | 0.00% |
| LIK.DE | LIMES Schlosskliniken AG | Healthcare | $199.75M | 570.00 EUR | −4.20% | −0.87% |
| ORIOLA.HE | Oriola Oyj | Healthcare | $195.27M | 0.90 EUR | −28.57% | −0.33% |
| BLC.PA | Bastide Le Confort Médical SA | Healthcare | $189.61M | 22.30 EUR | −23.76% | −2.83% |
| CARA.ST | Carasent AB (publ) | Healthcare | $178.28M | 25.25 SEK | −14.41% | +1.00% |
| FLERIE.ST | Flerie AB (publ) | Healthcare | $172.03M | 19.25 SEK | −48.78% | −3.02% |
| SANION.ST | Saniona AB (publ) | Healthcare | $171.29M | 11.83 SEK | −58.20% | −15.32% |
| DXRX.L | Diaceutics PLC | Healthcare | $169.64M | 143.50 GBP | −20.28% | +8.71% |
| ALCGM.PA | Cegedim SA | Healthcare | $166.24M | 10.26 EUR | −32.94% | +1.38% |
| VME.DE | Viromed Medical AG | Healthcare | $164.76M | 6.50 EUR | −23.08% | −15.03% |
| ALSEN.PA | Sensorion SA | Healthcare | $164.03M | 0.28 EUR | −65.59% | −0.71% |
| BINV.ST | BioInvent International AB (publ) | Healthcare | $162.35M | 24.30 SEK | −35.97% | +5.42% |
| NYKD.OL | Nykode Therapeutics AS | Healthcare | $160.76M | 4.64 NOK | −10.25% | +45.68% |
| PHO.OL | Photocure ASA | Healthcare | $157.00M | 54.00 NOK | −32.33% | −0.18% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | Healthcare | $154.41M | 20.00 PLN | −26.47% | −0.99% |
| S2B.WA | Syn2bio S.A. | Healthcare | $151.66M | 63.00 PLN | −34.78% | −9.12% |
| MRC.WA | Mercator Medical S.A. | Healthcare | $148.80M | 60.40 PLN | −5.18% | +18.43% |
| CRNO-B.ST | Cereno Scientific AB (publ) | Healthcare | $148.23M | 4.71 SEK | −57.60% | +0.13% |
| BICO.ST | BICO Group AB (publ) | Healthcare | $147.45M | 19.92 SEK | −24.49% | +36.25% |
| GENO.ST | Genovis AB (publ.) | Healthcare | $146.60M | 20.15 SEK | −22.05% | +2.81% |
| V5P.F | Vytrus Biotech, S.A. | Healthcare | $146.35M | 17.60 EUR | −18.52% | +1.73% |
| EKF.L | EKF Diagnostics Holdings plc | Healthcare | $145.56M | 24.70 GBP | −22.81% | −5.00% |
| PAX.ST | Paxman AB (publ) | Healthcare | $139.52M | 57.50 SEK | −28.84% | +26.37% |
| SCLP.L | Scancell Holdings plc | Healthcare | $136.80M | 9.70 GBP | −67.12% | −2.02% |
| SLV.WA | Selvita S.A. | Healthcare | $136.16M | 28.60 PLN | −42.11% | +7.52% |
| HPHA.DE | Heidelberg Pharma AG | Healthcare | $135.27M | 2.52 EUR | −45.69% | −2.70% |
| SEDANA.ST | Sedana Medical AB (publ) | Healthcare | $132.45M | 12.02 SEK | −29.54% | +23.92% |
| MVIR.ST | Medivir AB (publ) | Healthcare | $131.70M | 2.08 SEK | −27.90% | +14.29% |
| XI3.F | Bioceltix S.A. | Healthcare | $131.58M | 20.40 EUR | −28.67% | +7.59% |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | Healthcare | $124.97M | 74.00 PLN | −17.04% | −0.80% |
| BVXP.L | Bioventix PLC | Healthcare | $124.26M | 1,750.00 GBP | −31.37% | +15.89% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.